Acura Pharmaceuticals

ACUR

Delisted

ACUR was delisted on the 22nd of February, 2017.

Fund managers haven’t disclosed any holdings of ACUR yet.

ACUR Hedge Fund Activity: Q1 2026 in Review

1 of the 8,128 institutional investors tracked by Wall St. Rank reported a position in Acura Pharmaceuticals (ACUR) for Q1 2026, worth a combined $5.

Fund positioning in ACUR was balanced in Q1 2026: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

1 institutional investor held Acura Pharmaceuticals (ACUR) as of Q1 2026, unchanged from Q4 2025.
Funds reported $5 of Acura Pharmaceuticals stock for Q1 2026.
0 funds opened new Acura Pharmaceuticals positions in Q1 2026 and 0 closed out.

Based on aggregated 13F filings for Q1 2026.